There is a lot for investors to think about. To help you navigate it all, J.P Morgan's Q3 Guide to the Markets is here. Compiled by David Kelly and the J.P Morgan Funds market strategy team ...

The U.S. stock market is near an all-time high. And as the economy continues to recover, investors are preparing for rising interest rates. But they also have China's economic slowdown, emerging ...

Yet, getting out of the markets at this time—or any time—is the wrong move, says George Gatch, CEO of J.P. Morgan Asset Management, a unit of JPMorgan Chase. The Economic Policy Uncertainty ...

J.P. Morgan analysts ranked the global assets by their relative value and volatility. Emerging markets equities (EEM) have lagged, are cheap, and under-owned, J.P. Morgan strategists said.

JP Morgan posted stronger-than-expected fourth quarter earnings Wednesday as dealmaking help boost the group's bottom line and offset an overall slide in net interest income tied to lower Federal ...

Analysts at JP Morgan and BMO Capital Markets downgraded Air Products and Chemicals Inc (NYSE:APD) on concerns over earnings growth, currency headwinds, and management transition.

J.P. Morgan analyst Jessica Fye maintained a Buy rating on Ascendis Pharma (ASND – Research Report) today and set a price target of $167.00.

Jan 16 (Reuters) - J.P.Morgan estimated spending on data centers could contribute between 10-20 basis points to U.S. economic growth in 2025-2026 as technology companies race to benefit from the ...

J.P. Morgan analyst Sandeep Deshpande maintained a Hold rating on Telefonaktiebolaget LM Ericsson Class B (0O87 – Research Report) today and ...

Ciena (NYSE:CIEN) was upgraded to Overweight from Neutral by J.P. Morgan following a 21% plunge on Monday related to DeepSeek ...

CFO Aradhana Sarin outlined AstraZeneca’s plans at the 2025 JP Morgan Healthcare Conference ... concerted efforts to break into the obesity market, and has tried going through the deal rout ...